BioNTech SE (BNTX) EBIAT (2018 - 2025)
Historic EBIAT for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$33.6 million.
- BioNTech SE's EBIAT fell 11542.21% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$631.2 million, marking a year-over-year decrease of 2574.71%. This contributed to the annual value of -$710.9 million for FY2024, which is 17102.64% down from last year.
- BioNTech SE's EBIAT amounted to -$33.6 million in Q3 2025, which was down 11542.21% from -$437.6 million recorded in Q2 2025.
- Over the past 5 years, BioNTech SE's EBIAT peaked at $4.2 billion during Q1 2022, and registered a low of -$869.9 million during Q2 2024.
- Over the past 5 years, BioNTech SE's median EBIAT value was $492.7 million (recorded in 2023), while the average stood at $1.1 billion.
- Its EBIAT has fluctuated over the past 5 years, first skyrocketed by 82798755377.65% in 2021, then tumbled by 31957.5% in 2024.
- Quarter analysis of 5 years shows BioNTech SE's EBIAT stood at $3.6 billion in 2021, then crashed by 35.81% to $2.3 billion in 2022, then crashed by 78.81% to $492.7 million in 2023, then crashed by 43.72% to $277.3 million in 2024, then tumbled by 112.1% to -$33.6 million in 2025.
- Its last three reported values are -$33.6 million in Q3 2025, -$437.6 million for Q2 2025, and -$437.4 million during Q1 2025.